Liu Zhengqing, chairman of Hanson Pharmaceutical, made a profit of 1.34 million yuan in short -term transactions, and was fined 100,000 by the Securities Regulatory Bureau

Zhongxin Jingwei, September 23 (Wang Yuling) On the 23rd, Hansen Pharmaceutical announced that the chairman and president Liu Zhengqing was issued by the Hunan Supervision Bureau of the China Securities Regulatory Commission (hereinafter referred to as the Hunan Securities Regulatory Bureau) due to short -term transactions. The "Administrative Penalties Prior to the Notice" warned it and fined 100,000 yuan.

The Hunan Securities Regulatory Bureau reported that Liu Zhengqing asked "Hu Moumou" to open a capital account in 2014, transferred to the source of funds for Liu Zhengqing's own funds and borrowing funds, and the transfer of bank transfers transferred funds to Liu Zhengqing's bank account and repaid repayment Borrowing, the third -party depository bank account of the "Hu Moumou" securities account was also kept by Liu Zhengqing. From February 27, 2015 to July 28, 2020, the "Hu Moumou" securities account trading Hansen Pharmaceutical was jointly operated by Liu Zhengqing and "Liu Moumou".

In actual profit, from February 27, 2015 to July 28, 2020, the account has a total of 28 trading days of Hanson Pharmaceutical Stocks, with a cumulative purchase of 672,800 shares, with a transaction value of 11.379 million yuan. 186.22 million shares, the turnover of 31.9573 million yuan.

The Hunan Securities Regulatory Bureau stated that combined with account opening, capital exchanges, trading equipment and inquiry transcripts, he believed that Liu Zhengqing was the actual controller of the "Hu Moumou" securities account. At present, Liu Zhengqing's earnings through short -term transactions have returned to Hansen Pharmaceutical.

According to Article 44 of the Securities Law, companies, which are traded by other national securities trading venues approved by listed companies and shares in the State Council holding more than 5 % of the shareholders, directors, supervisors, and senior managers of shares of shares, hold them. Some companies' stocks or other equity securities sold within six months after buying, or they bought them within six months after they were sold. Its income. However, the securities company holds more than 5 % of the shares of the shares of the after -sales stocks, and except for other circumstances stipulated by the State Council's securities supervision and management agency.

According to Article 189 of the Securities Law, directors, supervisors, senior management personnel, and holding more than 5 % of the company's shares of the company approved by listed companies and shares in the State Council Shareholders who violate the provisions of Article 44 of the Law, buy and sell the company's shares or other securities of equity, will give warnings and impose a fine of 100,000 yuan or less.

According to the 2021 annual report of Hansen Pharmaceutical, Liu Zhengqing was born in October 1964 and Chinese nationality. Former director and deputy factory director of Yiyang Pharmaceutical Factory, chairman and general manager of Hunan Yiyang Pharmaceutical Co., Ltd., executive deputy general manager of Hunan Hansen Pharmaceutical Co., Ltd., and vice chairman and president of Hunan Hansen Pharmaceutical Co., Ltd. He is currently the chairman and president of Hunan Hanson Pharmaceutical Co., Ltd.

(For more report clues, please contact Wang Yuling, the author of this article: [email protected]) (Zhongxin Jingwei APP)

(The views in the article are for reference only, do not constitute investment suggestions, have risks in investment, and need to be cautious to enter the market.)

Editor in charge: Li Zhongyuan

Pay attention to the official WeChat public account of JWVIEW (JWVIEW) to get more elite financial information.

- END -